Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Enterprise Products Partners
EPD
$82.2B
| $45.1M | 0.04% |
1,741,765
+651,499
| +60% | +$16.7M |
|
202
Phreesia
PHR
$699M
| $44.5M | 0.04% |
1,377,363
+81,533
| +6% | +$2.87M |
|
203
Alexandria Real Estate Equities
ARE
$8.77B
| $43.7M | 0.04% |
347,712
-58,124
| -14% | -$8.54M |
|
204
Patterson-UTI
PTEN
$3.85B
| $43.7M | 0.04% |
3,732,080
-998,164
| -21% | -$14.6M |
|
205
Amphenol
APH
$211B
| $43.5M | 0.04% |
1,064,810
+44,984
| +4% | +$1.78M |
|
|
ROIC
206
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $43.3M | 0.04% |
3,103,715
-736,569
| -19% | -$10.7M |
|
207
Adecoagro
AGRO
$1.35B
| $42.5M | 0.04% |
5,254,667
+80,954
| +2% | +$651K |
|
208
MPLX
MPLX
$61.1B
| $42.1M | 0.04% |
1,223,440
+457,095
| +60% | +$15.7M |
|
209
Hilton Worldwide
HLT
$70.3B
| $42.1M | 0.04% |
298,760
-33,703
| -10% | -$4.75M |
|
210
GE HealthCare
GEHC
$31.5B
| $41.7M | 0.04% |
+508,823
| New | +$36.3M |
|
211
Ralph Lauren
RL
$22.8B
| $41.7M | 0.04% |
357,418
-101,514
| -22% | -$12M |
|
|
SPR
212
DELISTED
Spirit AeroSystems
SPR
| $41.7M | 0.04% |
1,207,183
+10,380
| +0.9% | +$348K |
|
213
Houlihan Lokey
HLI
$8.93B
| $41.2M | 0.04% |
471,159
+58,772
| +14% | +$5.53M |
|
214
Enterprise Financial Services Corp
EFSC
$2.45B
| $40.8M | 0.04% |
915,298
-386,405
| -30% | -$19.8M |
|
215
Fortive
FTV
$18.2B
| $40.6M | 0.04% |
791,135
-959,024
| -55% | -$48.2M |
|
216
Diamondback Energy
FANG
$54B
| $40.5M | 0.04% |
299,577
-45,829
| -13% | -$6.39M |
|
217
CoStar Group
CSGP
$12.1B
| $40.4M | 0.04% |
586,416
+1,780
| +0.3% | +$131K |
|
218
East-West Bancorp
EWBC
$18.4B
| $40.2M | 0.04% |
723,654
+160,263
| +28% | +$11.1M |
|
219
TotalEnergies
TTE
$190B
| $40M | 0.04% |
677,747
+69,719
| +11% | +$4.29M |
|
220
Inspire Medical Systems
INSP
$1.81B
| $39.6M | 0.04% |
169,147
+408
| +0.2% | +$103K |
|
221
MaxLinear
MXL
$6.59B
| $39.3M | 0.04% |
1,114,856
+262,336
| +31% | +$9.5M |
|
222
Apollo Global Management
APO
$75.6B
| $38.7M | 0.04% |
612,274
-43,271
| -7% | -$2.9M |
|
223
Freshpet
FRPT
$3.05B
| $38.4M | 0.04% |
580,808
-167,403
| -22% | -$10.3M |
|
224
Wabtec
WAB
$50.6B
| $38.2M | 0.04% |
377,819
-55,232
| -13% | -$5.64M |
|
225
Insulet
PODD
$11.5B
| $38.1M | 0.03% |
119,341
+21,555
| +22% | +$6.39M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.